Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental 'Smart Bomb' drug targets tough cancers in human trial

NCT ID NCT06303505

Summary

This early-stage trial is testing a new cancer drug called TUB-040 in people with advanced ovarian cancer or a type of lung cancer that has stopped responding to standard treatments. The drug works like a 'smart bomb'—it's designed to find cancer cells and deliver a powerful chemotherapy directly to them while sparing healthy cells. Researchers will give increasing doses to find the safest amount that still fights cancer effectively, then compare doses to determine the best one for patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arensia Exploratory Medicine

    RECRUITING

    Cluj-Napoca, Romania

    Contact Email: •••••@•••••

  • Arensia Exploratory Medicine

    RECRUITING

    Kyiv, Ukraine

    Contact Email: •••••@•••••

  • Charité Universitätsmedizin Berlin

    RECRUITING

    Berlin, 10117, Germany

    Contact Email: •••••@•••••

  • Christ Hospital

    RECRUITING

    Cincinnati, Ohio, 45219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Clínica universidad de Navarra

    RECRUITING

    Madrid, 28027, Spain

    Contact Email: •••••@•••••

  • Guy's Hospital

    RECRUITING

    London, SE1 9RT, United Kingdom

    Contact Email: •••••@•••••

  • Mount Sinai

    RECRUITING

    New York, New York, 10011, United States

    Contact Email: •••••@•••••

  • NEXT Oncology Madrid

    RECRUITING

    Madrid, 28223, Spain

    Contact Email: •••••@•••••

  • Next Oncology Dallas

    RECRUITING

    Irving, Texas, 75039, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Next Oncology Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-••••

  • OU Health Stephenson Cancer Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

    Contact Email: •••••@•••••

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210#, United States

    Contact Email: •••••@•••••

  • The University of Alabama

    RECRUITING

    Birmingham, Alabama, 35294, United States

    Contact Email: •••••@•••••

  • UZ Leuven

    RECRUITING

    Leuven, 3000, Belgium

    Contact Email: •••••@•••••

  • University Hospital Cologne Department of Internal Medicine I

    RECRUITING

    Cologne, 50937, Germany

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.